{"investor":{"slug":"carma-fund","name":"Carma Fund","website":null,"x_handle":null,"logo":"https://recentfunding.com/logo/u/aHR0cHM6Ly9pbWFnZXMuY3J1bmNoYmFzZS5jb20vaW1hZ2UvdXBsb2FkL2pxdXVybmp5cmVoeWNxdDF6MzVz","type":"fund","companies":1,"deals":1,"deals_12m":1,"leads":0,"round_capital":3800000,"latest_deal":{"date":"2026-09-09","stage":"seed","amount_usd":3800000,"company":{"slug":"allogenetics","name":"Allogenetics"}}},"profile":null,"fund_returns":[],"portfolio":[{"slug":"allogenetics","name":"Allogenetics","logo":"https://recentfunding.com/logo/u/aHR0cHM6Ly9pbWFnZXMuY3J1bmNoYmFzZS5jb20vaW1hZ2UvdXBsb2FkL2I3Zjk2MzBhMWQwYjQxYjI5Y2UzY2U4MzgzNDZiYTU0","crypto":false,"categories":["health-bio"],"total_raised":3800000,"latest_raise":{"date":"2026-09-09","stage":"seed","amount_usd":3800000,"source_url":"https://www.biospace.com/press-releases/allogenetics-raises-3-8-million-pre-series-a-to-advance-novel-ex-vivo-gene-therapy-approach-to-improve-organ-transplantation-outcomes"},"rounds_with_investor":[{"date":"2026-09-09","stage":"seed","amount_usd":3800000,"source_url":"https://www.biospace.com/press-releases/allogenetics-raises-3-8-million-pre-series-a-to-advance-novel-ex-vivo-gene-therapy-approach-to-improve-organ-transplantation-outcomes","lead":false}]}],"top_categories":[{"key":"health-bio","label":"Health and bio","companies":1,"share":1}],"allocation":{"stages":[{"key":"seed","label":"seed","deals":1,"capital":3800000,"share":1}],"years":[{"year":"2026","deals":1,"capital":3800000,"share":1}]},"co_investors":[{"slug":"nbank-capital","name":"NBank Capital","logo":"https://recentfunding.com/logo/u/aHR0cHM6Ly9pbWFnZXMuY3J1bmNoYmFzZS5jb20vaW1hZ2UvdXBsb2FkL2pweDBmN3F1enh2enU4Zm5lZXVl","type":"fund","shared_rounds":1,"last_shared":"2026-09-09"},{"slug":"life-science-valley-wachstumsfond","name":"Life Science Valley Wachstumsfond","logo":"https://recentfunding.com/logo/u/aHR0cHM6Ly9pbWFnZXMuY3J1bmNoYmFzZS5jb20vaW1hZ2UvdXBsb2FkL3NkdTMzY2Fwa3VqbXY5eTdxcW1r","type":"fund","shared_rounds":1,"last_shared":"2026-09-09"}]}